Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.
Bottcher, J., Dilworth, D., Reiser, U., Neumuller, R.A., Schleicher, M., Petronczki, M., Zeeb, M., Mischerikow, N., Allali-Hassani, A., Szewczyk, M.M., Li, F., Kennedy, S., Vedadi, M., Barsyte-Lovejoy, D., Brown, P.J., Huber, K.V.M., Rogers, C.M., Wells, C.I., Fedorov, O., Rumpel, K., Zoephel, A., Mayer, M., Wunberg, T., Bose, D., Zahn, S., Arnhof, H., Berger, H., Reiser, C., Hormann, A., Krammer, T., Corcokovic, M., Sharps, B., Winkler, S., Haring, D., Cockcroft, X.L., Fuchs, J.E., Mullauer, B., Weiss-Puxbaum, A., Gerstberger, T., Boehmelt, G., Vakoc, C.R., Arrowsmith, C.H., Pearson, M., McConnell, D.B.(2019) Nat Chem Biol 15: 822-829
- PubMed: 31285596 
- DOI: https://doi.org/10.1038/s41589-019-0310-x
- Primary Citation of Related Structures:  
6G24, 6G25, 6G27, 6G29, 6G2B, 6G2C, 6G2E, 6G2F, 6G2O, 6G3P, 6G3T - PubMed Abstract: 
Here, we report the fragment-based discovery of BI-9321, a potent, selective and cellular active antagonist of the NSD3-PWWP1 domain. The human NSD3 protein is encoded by the WHSC1L1 gene located in the 8p11-p12 amplicon, frequently amplified in breast and squamous lung cancer ...